Wednesday, July 31, 2019

Apellis Pharmaceuticals EPS beats by $0.17

Apellis Pharmaceuticals (NASDAQ:APLS): Q2 GAAP EPS of -$0.61 beats by $0.17.
Cash and cash equivalents of $289.13M
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.